Cannabinoid Effect and Safety in Spasticity Following Stroke: A Double-Blind Randomized Placebo-Controlled Study

BACKGROUND: Nabiximols is a cannabis-based drug to treat spasticity-associated symptoms currently approved for patients with multiple sclerosis only. Cannabinoids are useful in an increasing number of medical conditions but may bear an increased risk for cardiovascular events. SativexStroke is a dou...

Descripción completa

Detalles Bibliográficos
Autores principales: Marinelli, Lucio, Puce, Luca, Mori, Laura, Leandri, Massimo, Rosa, Gian Marco, Currà, Antonio, Fattapposta, Francesco, Trompetto, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261779/
https://www.ncbi.nlm.nih.gov/pubmed/35812088
http://dx.doi.org/10.3389/fneur.2022.892165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261779/
https://www.ncbi.nlm.nih.gov/pubmed/35812088
http://dx.doi.org/10.3389/fneur.2022.892165

Ejemplares similares